ICBI Companies

Current Companies

Anagin

Developing new therapies for pain and traumatic brain injury.

Thumbnail logos for atelerix life sciences and airbase breathing

Atelerix Life Sciences / Airbase Breathing

Developing new therapies for pain and traumatic brain injury to be used in the community, in the hospital and in response to the threat of Opioid Induced Respiratory Depression in terrorism.

Ciconia

Ciconia Biosciences, a preclinical Partner Research Organization (PtRO), is dedicated to expediting the discovery of next generation therapies for diverse health disorders.

Degrome Therapeutics

Degrome Theraputics

Degrome Therapeutics, Inc. is specialized in discovery and development of small molecule degraders of neurodegenerative disease-causing proteins as the first-in-class drugs. The company was founded by Drs. Anita Bellail and Chunhai Hao in 2023 in Indiana after they identified hit compounds as Alzheimer Precursor Protein (APP) degrader.

E & E BioClub

E&E BioClub focuses on facilitating the advancement of biotherapeutics into the clinical stage by developing cost-effective and scalable manufacturing processes.

HB Therapeutics

Discovery and development of small molecule protein degraders as new anticancer drugs.

Health Smart Technologies

Health Smart Technologies, Inc. is an Indiana University based company that merges Engineering and Rehabilitation expertise to develop Smart technology advancing manual therapy.

Monon Bioventures

Assisting world-class investigators to navigate the early stage challenges of translating their research into the clinic.

Scioto Biosciences

Developing innovative therapies devoted to having a significant impact on the delivery of microbiome therapeutics.

Simmaron Research

Simmaron Research is working to improve the diagnosis, treatment and medical understanding of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and other neuroimmune diseases.

Skolnick and Company

Stephen Skolnick and Company is harnessing the power of the human gut microbiome to produce new and innovative foods for human health.

Vasculonics

Treatment of vascular complications.

Graduated Companies

Femtera

Leading discovery & clinical diagnostic applications of novel metabolite biomarkers for the detection of catastrophic diseases.

Genezen

Offers contract viral vector production, transduced cell manufacturing, and clinical trial testing services by leveraging the expertise of the nation’s leading academic vector production and research laboratories.

Early is Good

Co-Founded by Dr. Thakshila Liyanage and Asel Liyanage, Early is Good is a cancer diagnostic company taking aim at first creating a simple urine test (BCDx – biomarker detection) for bladder cancer.